November 15, 2022-November 17, 2022 Selecting Outcomes That Are Truly Meaningful to Patients Panel discussion at the National Organization of Rare Disorders (NORD) Breakthrough Summit in Washington, DC, held October 15 –
November 15, 2022 C-Path and Cerveau Technologies, Inc. Announce Data Sharing Collaboration to Accelerate Drug Development for Alzheimer’s Disease and Related Dementias TUCSON, Ariz., November 15, 2022 — The Critical Path for Alzheimer’s Disease (CPAD) at the Critical Path Institute (C-Path) an
November 14, 2022-November 15, 2022 10th Annual Drug Repositioning & Repurposing Conference November 14-15, Washington, DC Join us at the 10TH ANNUAL DRUG REPOSITIONING AND REPURPOSING CONFERENCE, where attendees will mee
November 10, 2022 C-Path and EFACTS Announce Data Sharing Agreement Making RDCA-DAP the Largest Worldwide Database for Friedreich’s Ataxia TUCSON, Ariz., Nov. 10, 2022 — Critical Path Institute (C-Path) and the European Friedreich’s Ataxia Consortium for Translatio
November 9, 2022 Innovative Use of Healthcare Data, ERN Data Management Strategy Multistakeholder Workshop The presentations of the workshop sessions are now available. In order to download the presentations...
November 3, 2022 eCOA Consortium Announces New Article for Applied Clinical Trials C-Path’s eCOA Consortium is pleased to announce that “Survey Investigates Backup Solution Adoption for ePRO Systems” has bee
November 2, 2022 C-Path and Eisai Data Sharing Collaboration to Include Lennox-Gastaut Syndrome Registry and Clinical Trial Data TUCSON, Ariz., Nov. 2, 2022 — Critical Path Institute (C-Path) and the Eisai Co., Ltd. (Eisai) today announced a joint collabora
October 31, 2022 FDA Expands Support of C-Path CDRC to Automate EHR Data Extraction Emory, Johns Hopkins Medicine, Infectious Disease Data Observatory/Oxford, Society of Critical Care Medicine and May
October 29, 2022 View Now | The Role of Integrated Datasets in Addressing Rare Diseases Research Challenges Gaining knowledge on rare diseases is limited by the scarcity and dispersity of patient data. Sequencing technologies have greatly
